SMO ClinPlus CO.,LTD. (SHE:301257)

China flag China · Delayed Price · Currency is CNY
57.14
+0.78 (1.38%)
At close: Apr 28, 2026
Market Cap4.51B +75.3%
Revenue (ttm)819.09M +1.1%
Net Income121.55M +14.6%
EPS1.38 -9.4%
Shares Out79.00M
PE Ratio41.44
Forward PEn/a
Dividend0.27 (0.48%)
Ex-Dividend DateNov 28, 2025
Volume1,985,391
Average Volume2,358,830
Open56.41
Previous Close56.36
Day's Range56.41 - 58.76
52-Week Range26.23 - 85.00
Beta1.22
RSI44.67
Earnings DateApr 29, 2026

About SMO ClinPlus CO.,LTD.

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2009
Employees 4,271
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301257
Full Company Profile

Financial Performance

In 2024, SMO ClinPlus CO.,LTD.'s revenue was 803.73 million, an increase of 5.75% compared to the previous year's 760.04 million. Earnings were 106.43 million, a decrease of -21.01%.

Financial Statements